Price target
4,195.720.000.00%
The 16 analysts offering 1 year price forecasts for ASND/N have a max estimate of — and a min estimate of —.
Analyst rating
Based on 16 analysts giving stock ratings to ASND/N in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
ASND/N EPS for the last quarter is −13.81 MXN despite the estimation of −21.18 MXN. In the next quarter EPS is expected to reach −31.84 MXN. Track more of ASCENDIS PHARMA A/S financials and stay on top of what is up with the company.
In the next quarter ASCENDIS PHARMA A/S revenue is expected to reach 2.03 B MXN. Check out ASCENDIS PHARMA A/S revenue and earnings and make informed decisions.
According to analysts, ASND/N price target is 4,195.72 MXN with a max estimate of 5,885.38 MXN and a min estimate of 3,300.64 MXN. Check if this forecast comes true in a year, meanwhile watch ASCENDIS PHARMA A/S stock price chart and keep track of the current situation with ASND/N news and stock market news.
We've gathered opinions of 16 analysts rating ASND/N stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.